Disruptive Technologies for Drugging the Undruggable
October 1, 2025 @ 09:00 – 17:00 CEST
SciLifeLab Science Summit 2025
Are you ready to explore the cutting-edge for the future of drug discovery? Mark your calendar for the SciLifeLab Science Summit 2025, an event focusing on novel technologies as drivers to find new modalities for disease intervention and drug innovation for precision medicine.
This full-day symposium will bring together leading scientists, industry experts, and innovators to discuss the breakthroughs and challenges in addressing previously inaccessible drug targets. Join us at Aula Medica, Karolinska Institutet, for a packed program featuring high-impact international presentations, panel discussions, and networking opportunities.
Junior researchers are encouraged to participate with poster presentations – with the opportunity to be selected to give a short talk.
Registration
Deadlines
- Abstract submission by August 24, also for oral presentations.
- Confirmation of acceptance by September 1.
- Registration closes September 21.
Speakers
Any target, every time: how proximity-based drugs are redefining pharmacotherapy
Ray Deshaies, Amgen / Caltech
Applying lessons learned from Duchenne exon skipping dystrophy to developing exon skipping for patients with nanorare diseases
Annemieke Aartsma-Rus, Leiden University Medical Center
AI and Machine Learning for Next-Generation Drug Discovery
Eva Nittinger, AstraZeneca
Encoded combinatorial libraries and the dream of Paul Ehrlich
Dario Neri, Philogen / ETHZ
Empowering immunotherapy with cellular reprogramming
Felipe Pereira, Lund university
Oligonucleotide therapy – from bench to beside
Li-ming Gan, Ribocure Pharmaceuticals
The 2025 Drug Discovery and Development Pipeline
Jessica Martinsson, SwedenBio
SciLifeLab – a breeding ground for innovation
Mia Phillipson, SciLifeLab
Program
| 09:00 | Registration |
| 09:30 | Welcome words Introduction of the day |
| 09:40 | Any target, every time: how proximity-based drugs are redefining pharmacotherapy Ray Deshaies, Amgen / Caltech |
| 10:20 | The 2025 Drug Discovery and Development Pipeline Jessica Martinsson, SwedenBio |
| 10:40 | Coffee break & poster session |
| 11:30 | Applying lessons learned from Duchenne exon skipping dystrophy to developing exon skipping for patients with nanorare diseases Annemieke Aartsma-Rus, Leiden University Medical Center |
| 12:00 | Empowering immunotherapy with cellular reprogramming Felipe Pereira, Lund university |
| 12:10 | Oligonucleotide therapy – from bench to beside Li-ming Gan, Ribocure Pharmaceuticals |
| 12:20 | Pre-lunch wrap-up |
| 12:30 | Lunch & Poster Session |
| 13:40 | AI and machine learning for next-generation drug discovery Eva Nittinger, AstraZeneca |
| 14:10 | Selected short talks |
| 14:40 | Coffee break & poster session |
| 15:30 | Encoded combinatorial libraries and the dream of Paul Ehrlich Dario Neri, Philogen / ETHZ |
| 16:00 | SciLifeLab – a fertile ground for innovation Mia Phillipson, SciLifeLab |
| 16:20 | Panel discussion |
| 16:50 | Wrap-up, best poster award |
| 17:00 | Mingle |
Why Attend?
- Gain knowledge on the latest disruptive technologies shaping drug discovery for precision medicine and new treatments.
- Engage with top researchers and industry leaders driving change in the field.
- Opportunity to position your research for innovation.
Sponsor opportunity & Vendor exhibition
For more information on how you can support this event, or participate in the vendor exhibition, please contact SciLifeLab.
Scientific Committee
- Claes Wahlestedt, University of Miami
- Malin Lemurell, AstraZeneca
- Alexandra Teleki, Uppsala University
Organizing Committee
- Per Arvidsson, Karolinska Institutet/SciLifeLab
- Rebecka Klintenberg, Uppsala University/SciLifeLab
- Mats Ohlin, Lund University/SciLifeLab
- Kristian Sandberg, Uppsala University/SciLifeLab
- Contact: David Gotthold, SciLifeLab
Google Calendar 
iCalendar 
